Abstract:Objectives: Adipose tissue depots vary markedly in their ability to store and metabolize triglycerides, undergo beige adipogenesis and susceptibility to metabolic disease. The molecular mechanisms that underlie such heterogeneity are not entirely clear. Previously, we showed that TGF-β signaling suppresses beige adipogenesis via repressing the recruitment of dedicated beige progenitors. Here, we find that TGF-β signals dynamically regulate the balance between adipose tissue fibrosis and beige adipogenesis. Methods: We investigated adipose tissue depot-specific differences in activation of TGF-β signaling in response to dietary challenge. RNA-seq and fluorescence activated cell sorting was performed to identify and characterize cells responding to changes in TGF-β signaling status. Mouse models, pharmacological strategies and human adipose tissue analyses were performed to further define the influence of TGF-β signaling on fibrosis and functional beige adipogenesis. Results: Elevated basal and high-fat diet inducible activation of TGF-β/Smad3 signaling was observed in the visceral adipose tissue depot. Activation of TGF-β/Smad3 signaling was associated with increased adipose tissue fibrosis. RNA-seq combined with fluorescence-activated cell sorting of stromal vascular fraction of epididymal white adipose tissue depot resulted in identification of TGF-β/Smad3 regulated ITGA5+ fibrogenic progenitors. TGF-β/Smad3 signal inhibition, genetically or pharmacologically, reduced fibrosis and increased functional beige adipogenesis. TGF-β/Smad3 antagonized the beneficial effects of PPARγ whereas TGF-β receptor 1 inhibition synergized with actions of rosiglitazone, a PPARγ agonist, to dampen fibrosis and promote beige adipogenesis. Positive correlation between TGF-β activation and ITGA5 was observed in human adipose tissue, with visceral adipose tissue depots exhibiting higher fibrosis potential than subcutaneous or brown adipose tissue depots. Conclusions: Basal and high-fat diet inducible activation of TGF-β underlies the heterogeneity of adipose tissue depots. TGF-β/Smad3 activation promotes adipose tissue fibrosis and suppresses beige progenitors. Together, these dual mechanisms preclude functional beige adipogenesis. Controlled inhibition of TβRI signaling and concomitant PPARγ stimulation can suppress adipose tissue fibrosis and promote beige adipogenesis to improve metabolism.

Fibroblast growth factor 6 promotes adipocyte progenitor cell proliferation for adipose tissue homeostasis

Fgf6 Promotes Adipocyte Progenitor Cell Proliferation for Adipose Tissue Homeostasis

6-Gingerol, a Functional Polyphenol of Ginger, Promotes Browning Through an AMPK-Dependent Pathway in 3T3-L1 Adipocytes

Skeletal muscle–targeted delivery of Fgf6 protects mice from diet-induced obesity and insulin resistance

Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4) – a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity

[Fibroblast Growth Factor-1 Inhibits Wnt/β-catenin Pathway During Adipogenesis].

FSP1-positive Fibroblasts Are Adipogenic Niche and Regulate Adipose Homeostasis

Role of the CTRP6/AMPK Pathway in Kidney Fibrosis Through the Promotion of Fatty Acid Oxidation.

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis

Fibroblast Growth Factor-21 Maintains Glucose Homeostasis Through Influencing the Expansion and Function of Subcutaneous Adipose Tissue

FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation

Autophagy inhibition blunts PDGFRA adipose progenitors' cell-autonomous fibrogenic response to high-fat diet

FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.

Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses

Fibroblast Growth Factor 21 Increases Insulin Sensitivity Through Specific Expansion of Subcutaneous Fat

Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation

Fibroblast Growth Factor 21 Exerts Its Anti‐inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against obesity and hepatic steatosis

TGF-β antagonism synergizes with PPARγ agonism to reduce fibrosis and enhance beige adipogenesis

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells

FAP deficiency enhances thermogenesis and attenuates metabolic inflammation in diet-induced obesity